MSB 7.69% $1.19 mesoblast limited

Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-25

  1. 7,779 Posts.
    lightbulb Created with Sketch. 1337
    How does it contribute to the likelihood of approval?
    Having a factory that passes inspection is necessary, of course. But it doesn't mean the FDA is more likely to be convinced the cells work without further trials.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.